[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 984
Citations 0
Medical News & Perspectives
June 16, 2015

Margaret A. Hamburg, MD, Reflects on 6 Years at FDA

JAMA. 2015;313(23):2309-2310. doi:10.1001/jama.2015.3911

Margaret A. Hamburg, MD, the second woman nominated to be commissioner of the Food and Drug Administration (FDA), stepped down from the post in late March, just shy of 6 years on the job.

The agency’s responsibilities grew within weeks of Hamburg assuming the post, when President Obama signed a law allowing the FDA to regulate tobacco products. The speed of approvals quickened during her tenure, with the FDA greenlighting 51 novel drugs and biologics in 2014, the most in almost 20 years, Hamburg wrote in a blog post February 5 (http://1.usa.gov/19GXDeu). Among the drugs approved in 2014 were 4 novel systemic antibiotics, only 1 less than the number approved the entire previous decade, she wrote.

First Page Preview View Large
First page PDF preview
First page PDF preview